Log in
Enquire now
‌

US Patent 11648235 Treatment of glioblastoma

Patent 11648235 was granted and assigned to Cantex Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Cantex Pharmaceuticals
0
Current Assignee
‌
Cantex Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116482350
Patent Inventor Names
Stephen G. Marcus0
Date of Patent
May 16, 2023
0
Patent Application Number
181489220
Date Filed
December 30, 2022
0
Patent Citations
‌
US Patent 10363241 Substituted imidazole derivatives and methods of use thereof
0
‌
US Patent 11524942 Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine
0
Patent Primary Examiner
‌
Erich A Leeser
0
CPC Code
‌
A61P 25/00
0
‌
A61K 31/4164
0
‌
A61P 35/00
0
‌
A61K 31/495
0
‌
A61N 5/10
0

Methods of treating glioblastoma are provided comprising: administering a therapeutically effective amount of azeliragon, or a pharmaceutically acceptable salt thereof, and co-administering an effective amount of radiation therapy (RT), to a patient who has been diagnosed with glioblastoma. In another aspect, methods are provided for treating grade I, grade II, and grade III gliomas, the method comprising administering a therapeutically effective amount of azeliragon, or a pharmaceutically acceptable salt thereof, and co-administering an effective amount of radiation therapy (RT), to a patient who has been diagnosed with glioma.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11648235 Treatment of glioblastoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.